Clinical Trial Update: Comparison of Clinical and Radiographic Parameters in the Application of Cross-linked Hyaluronic Acid 1.8% and Enamel Matrix Derivative in Periodontal Regeneration. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing cross-linked hyaluronic acid 1.8% with enamel matrix derivative for periodontal regeneration in chronic periodontitis, with per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Bone Loss
• Periodontitis

Drugs mentioned

• Cross-linked hyaluronic acid 1.8%
• Enamel Matrix Derivative (enamel matrix derivative)

Snippet

Sponsor: University of Valencia | Conditions: Chronic Periodontitis, Periodontal Bone Loss | Phase 4 | Status: UNKNOWN